Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:53:03 EDT Sat 10 Oct 2026
Enter Symbol
or Name
USA
CA



Q:AVXL - ANAVEX LIFE SCIENCES CORPORATION - https://www.anavex.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AVXL - Q1.01.44·1.680.21.49-0.05-3.21,286.31,6844,8461.54  1.54  1.449.9499  1.51519:30:06Sep 2415 min RT 2¢

Recent Trades - Last 10 of 4846
Time ETExPriceChangeVolume
19:30:06Q1.51-0.031
19:30:04Q1.51-0.031
19:30:04Q1.51-0.031
19:23:06Q1.52-0.0265
19:07:52Q1.52-0.021
19:05:08Q1.51-0.03150
17:12:18Q1.51-0.031
16:38:15Q1.49-0.053
16:28:37Q1.49-0.0564,374
16:10:03Q1.49-0.051

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-24 10:00U:AVXLNews ReleaseAnavex Stockholders Elect All of the Company's Director Nominees at 2026 Annual Meeting
2026-09-18 09:49U:AVXLNews ReleasePVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences
2026-09-17 12:17U:AVXLNews ReleaseGlass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing "Functionally Inert Stewardship" in Support of PVG Asset Management's Call for Change
2026-09-14 19:30U:AVXLNews ReleasePVG Asset Management Believes ISS Acknowledges Anavex's Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance
2026-09-14 08:30U:AVXLNews ReleaseLeading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Six of Anavex's Highly Qualified Director Nominees
2026-09-10 14:46U:AVXLNews ReleasePVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign
2026-09-09 09:54U:AVXLNews ReleasePVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL)
2026-09-08 08:00U:AVXLNews ReleaseAnavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET
2026-09-03 17:46U:AVXLNews ReleasePVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company
2026-09-02 16:00U:AVXLNews ReleaseAnavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement
2026-09-01 17:35U:AVXLNews ReleasePVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.'s 2026 Annual Meeting
2026-08-25 08:00U:AVXLNews ReleaseAnavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
2026-08-17 08:00U:AVXLNews ReleaseAnavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
2026-08-11 08:00U:AVXLNews ReleaseAnavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders
2026-08-03 08:00U:AVXLNews ReleaseAnavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation
2026-07-30 08:00U:AVXLNews ReleaseAnavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
2026-05-22 08:00U:AVXLNews ReleaseAnavex Life Sciences Receives Expected Nasdaq Delinquency Notification
2026-05-06 07:00U:AVXLNews ReleaseAnavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
2026-04-14 07:30U:AVXLNews ReleaseAnavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease
2026-04-07 07:30U:AVXLNews ReleaseAnavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference